# IVPR (Inspire Veterinary Partners, Inc.) - SEC EDGAR Financial Statements

> Inspire Veterinary Partners, Inc. reported $15.56M in revenue and a net loss of $11.94M for the trailing twelve months ended September 30, 2025 (up 6.6% year over year), with a -52.2% operating margin.

- Canonical: https://convexityos.com/fundamentals/IVPR
- Markdown: https://convexityos.com/fundamentals/IVPR.md
- SEC CIK: 0001939365
- Reporting currency: USD
- Latest filing period: September 30, 2025
- Last synced: Nov 21, 2026, 05:16 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001939365&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $15.56M | +6.6% YoY |
| Operating Income | TTM | -$8.13M | -52.2% margin |
| Net Income | TTM | -$11.94M | -76.8% net margin |
| Diluted EPS | TTM | -- | Split-adjusted |
| Free Cash Flow | TTM | -$4.34M | -27.9% FCF margin |
| Cash & ST Investments | Sep 30, 2025 | -- | Total debt: $13.74M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- |
| **Revenue** | $16.59M | $16.68M | $9.83M |
| Total Operating Expenses | $25.62M | $23.85M | $13.35M |
| **Operating Income** | -$9.03M | -$7.17M | -$3.52M |
| **EBITDA** | -$7.69M | -$5.92M | -$2.92M |
| Interest Income | $53 | $21 | $1.0K |
| Income Before Tax | -$14.26M | -$14.79M | -$4.94M |
| Income Tax Expense | -- | -- | -$30K |
| **Net Income** | -$14.26M | -$14.79M | -$4.91M |

### Income Statement (Quarterly)

| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $4.32M | $4.28M | $3.64M | $3.32M | $4.05M | $4.39M | $4.83M | $3.78M |
| Total Operating Expenses | $6.28M | $6.90M | $5.65M | $4.86M | $6.28M | $6.78M | $7.69M | $6.19M |
| **Operating Income** | -$1.97M | -$2.62M | -$2.01M | -$1.54M | -$2.24M | -$2.39M | -$2.86M | -$2.41M |
| **EBITDA** | -$1.64M | -$2.36M | -$1.73M | -$1.23M | -$1.90M | -$2.05M | -$2.52M | -$2.07M |
| Interest Income | $4 | $13 | $8 | $7 | $44 | $0 | $2 | $3 |
| Income Before Tax | -$2.53M | -$3.03M | -$2.42M | -$3.97M | -$3.49M | -$3.39M | -$3.42M | -$4.14M |
| **Net Income** | -$2.53M | -$3.03M | -$2.42M | -$3.97M | -$3.49M | -$3.39M | -$3.42M | -$4.14M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $524K | $179K | $444K |
| **Cash & Short-Term Investments** | $524K | $179K | $444K |
| Accounts Receivable, Net | $41K | $29K | -- |
| Inventory | $517K | $572K | $582K |
| **Total Current Assets** | $2.02M | $1.35M | $1.74M |
| Property, Plant & Equipment, Net | $6.38M | $7.95M | $7.32M |
| Goodwill | $8.02M | $8.15M | $7.61M |
| Intangible Assets | $1.63M | $2.51M | $2.73M |
| Other Non-Current Assets | $54K | $13K | $29K |
| **Total Non-Current Assets** | $18.17M | $20.44M | $18.44M |
| **Total Assets** | $20.20M | $21.79M | $20.19M |
| Accounts Payable | $1.98M | $3.21M | $1.02M |
| **Total Current Liabilities** | $8.20M | $7.58M | $7.25M |
| Long-Term Debt | $11.98M | -- | -- |
| **Total Non-Current Liabilities** | $10.43M | $15.00M | $18.07M |
| **Total Liabilities** | $18.63M | $22.58M | $25.32M |
| **Total Debt (incl. Leases)** | $14.11M | $1.66M | $757K |
| Retained Earnings | -$36.35M | -$21.22M | -$6.24M |
| **Total Stockholders' Equity** | $1.56M | -$788K | -$5.14M |
| Total Equity | $1.56M | -$788K | -$5.14M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | -- | $524K | $681K | $69K | $179K | $1.96M |
| **Cash & Short-Term Investments** | -- | -- | -- | $524K | $681K | $69K | $179K | $1.96M |
| Accounts Receivable, Net | $29K | $184K | $4.4K | $41K | $116K | $341K | $29K | $242K |
| Inventory | $498K | $477K | $475K | $517K | $564K | $546K | $572K | $680K |
| **Total Current Assets** | $3.82M | $1.33M | $2.90M | $2.02M | $4.45M | $3.14M | $1.35M | $3.54M |
| Property, Plant & Equipment, Net | $6.89M | $7.03M | $6.28M | $6.38M | $6.49M | $7.97M | $7.95M | $7.31M |
| Goodwill | $9.09M | $8.99M | $8.02M | $8.02M | $8.02M | $8.15M | $8.15M | $7.61M |
| Intangible Assets | $1.18M | $1.43M | $1.48M | $1.63M | $1.86M | $2.31M | $2.51M | $2.19M |
| Other Non-Current Assets | $48K | $54K | $54K | $54K | $25K | $74K | $13K | $14K |
| **Total Non-Current Assets** | $20.13M | $19.48M | $17.76M | $18.17M | $17.95M | $20.26M | $20.44M | $17.76M |
| **Total Assets** | $23.96M | $20.81M | $20.66M | $20.20M | $22.40M | $23.40M | $21.79M | $21.30M |
| Accounts Payable | $1.70M | $1.88M | $1.77M | $1.98M | $2.07M | $3.52M | $3.21M | $2.30M |
| **Total Current Liabilities** | $9.72M | $10.05M | $7.47M | $8.20M | $7.03M | $8.45M | $7.58M | $5.09M |
| Long-Term Debt | $11.76M | $12.03M | $11.52M | $11.98M | $12.43M | -- | -- | -- |
| **Total Non-Current Liabilities** | $10.07M | $10.31M | $10.18M | $10.43M | $12.34M | $14.67M | $15.00M | $13.49M |
| **Total Liabilities** | $19.79M | $20.36M | $17.66M | $18.63M | $19.37M | $23.13M | $22.58M | $18.58M |
| **Total Debt (incl. Leases)** | $13.74M | $14.06M | $13.59M | $14.11M | $14.01M | $1.62M | $1.66M | $659K |
| Retained Earnings | -$44.33M | -$41.80M | -$38.77M | -$36.35M | -$31.73M | -$24.85M | -$21.22M | -$16.89M |
| **Total Stockholders' Equity** | $4.17M | $446K | $3.00M | $1.56M | $3.03M | $270K | -$788K | $2.71M |
| Total Equity | $4.17M | $446K | $3.00M | $1.56M | $3.03M | $270K | -$788K | $2.71M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- |
| Net Income | -$14.26M | -$14.79M | -$4.91M |
| Depreciation & Amortization | $1.34M | $1.25M | $596K |
| Stock-Based Compensation | $24K | $0 | -- |
| Change in Receivables | -$12K | -$152K | -- |
| Change in Inventory | $12K | $85K | -$230K |
| Change in Payables | -$1.23M | $2.19M | $974K |
| **Operating Cash Flow** | -$10.01M | -$3.82M | -$2.66M |
| Capital Expenditure | -$238K | -$384K | -$135K |
| **Free Cash Flow** | -$10.24M | -$4.20M | -$2.79M |
| **Investing Cash Flow** | -$238K | -$1.87M | -$14.67M |
| Common Stock Issued | $5.46M | $5.44M | -- |
| Share Repurchases | -$650K | -- | -- |
| **Financing Cash Flow** | $10.59M | $5.63M | $15.71M |
| **Net Change in Cash** | $345K | -$65K | -$1.61M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.53M | -$3.03M | -$2.42M | -$3.97M | -$3.49M | -$3.39M | -$3.42M | -$4.14M |
| Depreciation & Amortization | $330K | $258K | $275K | $309K | $340K | $341K | $347K | $337K |
| Change in Receivables | $155K | -$179K | $36K | $75K | -$76K | $302K | -$313K | $90K |
| Change in Inventory | -$21K | $38K | $41K | $47K | -$31K | -$29K | $26K | $183K |
| Change in Payables | -$175K | $105K | -$210K | -$94K | -$1.64M | $196K | $315K | $905K |
| **Operating Cash Flow** | -$1.28M | -$898K | -$1.37M | -$678K | -$6.31M | $150K | -$3.17M | -$755K |
| Capital Expenditure | -$43K | -$13K | -$20K | -$32K | -$26K | -$24K | -$157K | -$24K |
| **Free Cash Flow** | -$1.33M | -$911K | -$1.39M | -$709K | -$6.33M | $126K | -$3.33M | -$778K |
| **Investing Cash Flow** | -$43K | -$1.86M | -$20K | -$32K | -$26K | -$24K | -$157K | -$1.51M |
| Common Stock Issued | $0 | $140K | $2.15M | -$3.38M | -- | -- | $3.38M | -- |
| **Financing Cash Flow** | $1.51M | $1.30M | $2.53M | $552K | $7.01M | -$187K | $3.22M | $683K |
| **Net Change in Cash** | $183K | -$1.46M | $1.13M | -$158K | $674K | -$61K | -$110K | -$1.58M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- |
| **Operating Margin** | -54.4% | -43.0% | -35.8% |
| **Net Profit Margin** | -86.0% | -88.7% | -49.9% |
| Return on Equity (ROE) | -913.2% | -- | -- |
| Return on Assets (ROA) | -70.6% | -67.9% | -24.3% |
| Current Ratio | 0.25x | 0.18x | 0.24x |
| Quick Ratio | 0.18x | 0.10x | 0.16x |
| Debt to Equity | 9.03x | -- | -- |
| **Revenue Growth (YoY)** | -0.5% | +69.6% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -52.2% | -54.9% | -53.1% | -54.4% | -58.0% | -61.3% | -- | -- |
| **Net Profit Margin** | -76.8% | -84.4% | -86.1% | -86.0% | -84.7% | -110.0% | -- | -- |
| Return on Equity (ROE) | -286.5% | -2891.9% | -441.3% | -913.2% | -476.6% | -- | -6179.6% | -- |
| Return on Assets (ROA) | -49.9% | -62.0% | -64.2% | -70.6% | -64.5% | -- | -71.3% | -67.9% |
| Current Ratio | 0.39x | 0.13x | 0.39x | 0.25x | 0.63x | -- | 0.37x | 0.18x |
| Quick Ratio | 0.34x | 0.09x | 0.32x | 0.18x | 0.55x | -- | 0.31x | 0.10x |
| Debt to Equity | 3.30x | 31.50x | 4.52x | 9.03x | 4.62x | -- | 5.99x | -- |
| **Revenue Growth (YoY)** | +6.6% | -2.4% | -24.7% | -12.2% | -1.7% | -- | +12.8% | -- |
| Operating Cash Flow Growth (YoY) | -- | -700.0% | -- | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -822.8% | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
